Actively Recruiting
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
Led by Ain Shams University · Updated on 2025-03-03
30
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present study is to evaluate the protective impact of cardioprotective medications on the chemotherapy- induced cardiotoxicity.
CONDITIONS
Official Title
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willingness of the legal representative of research participant to participate in the study by giving "informed consent."
- Ability to take oral medication.
- Age 2-18 years at the time of diagnosis.
You will not qualify if you...
- Documented allergy to cardioprotective medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Faculty of Pharmacy, Ain Shams University
Cairo, Egypt, 11566
Actively Recruiting
2
Faculty of Pharmacy, Ain Shams University
Cairo, Egypt
Actively Recruiting
Research Team
C
Christen Said
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here